
ASHP is the largest association of pharmacy professionals in the United States, representing over 65,000 pharmacists, student pharmacists, and pharmacy technicians in all patient care settings, including hospitals, ambulatory clinics, and health-system community pharmacies. For over 80 years, ASHP has championed innovation in pharmacy practice, advanced education and professional development, and served as a steadfast advocate for members and patients. In addition, ASHP is an accrediting body for pharmacy residency and technician training programs, and provides comprehensive resources to support pharmacy professionals through every stage of their careers.
ASHP is the largest association of pharmacy professionals in the United States, representing over 65,000 pharmacists, student pharmacists, and pharmacy technicians in all patient care settings, including hospitals, ambulatory clinics, and health-system community pharmacies. For over 80 years, ASHP has championed innovation in pharmacy practice, advanced education and professional development, and served as a steadfast advocate for members and patients. In addition, ASHP is an accrediting body for pharmacy residency and technician training programs, and provides comprehensive resources to support pharmacy professionals through every stage of their careers.
Episodes

32 minutes ago
32 minutes ago
This episode series will focus on the identification and underlying etiologies of status epilepticus, review treatment recommendations, and compare available antiepileptic agents for the management of status epilepticus. CE for this episode expires 2 years after the date it was originally published.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

14 hours ago
14 hours ago
In this episode, Jeff Chalmers, immediate past-chair of the ASHP Section of Pharmacy Informatics and Technology, has a discussion with Distinguished Service Awardee for 2025, Darren Ferer, to discuss his service within the section and the role ASHP has played in his development as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

4 days ago
4 days ago
Insights & Connections: Shaping Pharmacy’s Future is an ASHP podcast series that brings people, perspectives, and ideas together to shape the future of pharmacy practice.
Through conversations with ASHP Executive Vice President & CEO Sam Calabrese and voices spanning the profession, each episode highlights the insights that emerge through connection and collaboration—and how shared perspectives are helping move pharmacy forward.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

7 days ago
7 days ago
There have been several reported measles outbreaks within the US with increasing frequency over the last decade. Recent changes to the CDC/ACIP further add to concern regarding the MMR vaccine and potential future illnesses.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Friday May 01, 2026
Friday May 01, 2026
This podcast highlights how the University of Rhode Island’s College of Pharmacy SSHP created and hosted a series of clinical pharmacist and alumni panels to help students explore a wide range of pharmacy career pathways. The conversation showcases the chapter’s goals, planning approach, and the value these events provided to student pharmacists.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Wednesday Apr 29, 2026
Hot Topics in Pharmacy: ASHP Advantage: Sourcing the Vaccine Resources
Wednesday Apr 29, 2026
Wednesday Apr 29, 2026
Experts shed light on the latest updates in pneumococcal disease and vaccinations, including updated guideline recommendations, how to apply them to different patient populations, and innovations to increase pharmacist administration of vaccines and associated patient education.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Tuesday Apr 28, 2026
Tuesday Apr 28, 2026
In this episode, we look at how pharmacy compliance intersects with drug diversion. Hear expert insights, real-world examples, and practical strategies to protect your practice and your patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Friday Apr 24, 2026
Friday Apr 24, 2026
Lucas Schulz speaks with Todd Lemke, recipient of the Section of Inpatient Care Practitioners Distinguished Service Award, about the value of ASHP and Section membership and how it has shaped his journey as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Thursday Apr 23, 2026
Thursday Apr 23, 2026
Interested in advocacy but don’t know where to start? Heard of advocacy as a professional obligation but not sure how to advocate? Join us for a discussion on how you can get involved with advocacy and overcome perceived barriers to participate regardless of your role in the pharmacy workforce! Advocacy is vital across the spectrum of pharmacy practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Wednesday Apr 22, 2026
Wednesday Apr 22, 2026
COVID-19 is an ongoing public health challenge, and the disease continues to spread to patients every day. Numerous factors can influence the risk of adverse outcomes from COVID-19 including vaccination status, the number and type of medical conditions, immunosuppression, and age, along with sociodemographic factors and nonpharmaceutical interventions. For high-risk patients with non-severe COVID-19, antiviral medications can reduce progression to severe COVID-19 and can reduce the risk of hospitalization and death. Despite guideline recommended use of these medications and demonstrated effectiveness, the use of COVID-19 antiviral medications is low.
Pharmacists are well positioned to help address the ongoing risks and disease burden associated with COVID-19 by recognizing patients at elevated risk who may benefit from treatment, assessing emerging clinical data that support antiviral use, and facilitating access to these therapies. This activity will provide an overview of the current status of COVID-19 across the United States and assess the role of antiviral treatments in improving patient outcomes.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
